Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Comorbid conditions as predictors of mortality in severe COPD–an eight-year follow-up cohort study

Eliasson, Gabriella ; Janson, Christer ; Johansson, Gunnar ; Larsson, Kjell ; Lindén, Anders ; Löfdahl, Claes Göran LU ; Sandström, Thomas and Sundh, Josefin (2023) In European clinical respiratory journal 10(1).
Abstract

Purpose: Co-morbidities are common in chronic obstructive pulmonary disease (COPD) and are associated with increased morbidity and mortality. The aim of the present study was to explore the prevalence of several comorbid conditions in severe COPD, and to investigate and compare their associations with long-term mortality. Methods: In May 2011 to March 2012, 241 patients with COPD stage 3 or 4 were included in the study. Information was collected on sex, age, smoking history, weight and height, current pharmacological treatment, number of exacerbations the recent year and comorbid conditions. At December 31st, 2019, mortality data (all-cause and cause specific) were collected from the National Cause of Death Register. Data were analyzed... (More)

Purpose: Co-morbidities are common in chronic obstructive pulmonary disease (COPD) and are associated with increased morbidity and mortality. The aim of the present study was to explore the prevalence of several comorbid conditions in severe COPD, and to investigate and compare their associations with long-term mortality. Methods: In May 2011 to March 2012, 241 patients with COPD stage 3 or 4 were included in the study. Information was collected on sex, age, smoking history, weight and height, current pharmacological treatment, number of exacerbations the recent year and comorbid conditions. At December 31st, 2019, mortality data (all-cause and cause specific) were collected from the National Cause of Death Register. Data were analyzed using Cox-regression analysis with gender, age, previously established predictors of mortality and comorbid conditions as independent variables, and all-cause mortality and cardiac and respiratory mortality, respectively, as dependent variables. Results: Out of 241 patients, 155 (64%) were deceased at the end of the study period; 103 patients (66%) died of respiratory disease and 25 (16%) of cardiovascular disease. Impaired kidney function was the only comorbid condition independently associated with increased all-cause mortality (HR (95% CI) 3.41 (1.47-7.93) p=0.004) and respiratory mortality (HR (95%CI) 4.63 (1.61 to 13.4), p = 0.005). In addition, age ≥70, BMI <22 and lower FEV1 expressed as %predicted were significantly associated with increased all-cause and respiratory mortality. Conclusion: In addition to the risk factors high age, low BMI and poor lung function; impaired kidney function appears to be an important risk factor for mortality in the long term, which should be taken into account in the medical care of patients with severe COPD.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
comorbidity, COPD, impaired kidney function, mortality, predictor
in
European clinical respiratory journal
volume
10
issue
1
article number
2181291
publisher
Taylor & Francis
external identifiers
  • pmid:36861117
  • scopus:85149373938
ISSN
2001-8525
DOI
10.1080/20018525.2023.2181291
language
English
LU publication?
yes
additional info
Publisher Copyright: © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
id
5f3b72d2-f737-4c3f-96ce-0ef36181d206
date added to LUP
2024-01-12 13:40:21
date last changed
2024-04-13 07:08:19
@article{5f3b72d2-f737-4c3f-96ce-0ef36181d206,
  abstract     = {{<p>Purpose: Co-morbidities are common in chronic obstructive pulmonary disease (COPD) and are associated with increased morbidity and mortality. The aim of the present study was to explore the prevalence of several comorbid conditions in severe COPD, and to investigate and compare their associations with long-term mortality. Methods: In May 2011 to March 2012, 241 patients with COPD stage 3 or 4 were included in the study. Information was collected on sex, age, smoking history, weight and height, current pharmacological treatment, number of exacerbations the recent year and comorbid conditions. At December 31st, 2019, mortality data (all-cause and cause specific) were collected from the National Cause of Death Register. Data were analyzed using Cox-regression analysis with gender, age, previously established predictors of mortality and comorbid conditions as independent variables, and all-cause mortality and cardiac and respiratory mortality, respectively, as dependent variables. Results: Out of 241 patients, 155 (64%) were deceased at the end of the study period; 103 patients (66%) died of respiratory disease and 25 (16%) of cardiovascular disease. Impaired kidney function was the only comorbid condition independently associated with increased all-cause mortality (HR (95% CI) 3.41 (1.47-7.93) p=0.004) and respiratory mortality (HR (95%CI) 4.63 (1.61 to 13.4), p = 0.005). In addition, age ≥70, BMI &lt;22 and lower FEV1 expressed as %predicted were significantly associated with increased all-cause and respiratory mortality. Conclusion: In addition to the risk factors high age, low BMI and poor lung function; impaired kidney function appears to be an important risk factor for mortality in the long term, which should be taken into account in the medical care of patients with severe COPD.</p>}},
  author       = {{Eliasson, Gabriella and Janson, Christer and Johansson, Gunnar and Larsson, Kjell and Lindén, Anders and Löfdahl, Claes Göran and Sandström, Thomas and Sundh, Josefin}},
  issn         = {{2001-8525}},
  keywords     = {{comorbidity; COPD; impaired kidney function; mortality; predictor}},
  language     = {{eng}},
  number       = {{1}},
  publisher    = {{Taylor & Francis}},
  series       = {{European clinical respiratory journal}},
  title        = {{Comorbid conditions as predictors of mortality in severe COPD–an eight-year follow-up cohort study}},
  url          = {{http://dx.doi.org/10.1080/20018525.2023.2181291}},
  doi          = {{10.1080/20018525.2023.2181291}},
  volume       = {{10}},
  year         = {{2023}},
}